Tripos to Sell Informatics Business to Vector Capital for $25.6M as First Step in Liquidation

Nov 20, 2006

NEW YORK (GenomeWeb News) - Tripos today said it has agreed to sell its Discovery Informatics business to San Francisco-based Vector Capital for $26.5 million in cash as an “initial step” in the liquidation of the company.

The transaction is expected to close in the first quarter of 2007.

Vector Capital is a boutique private equity firm that specializes in technology recapitalization deals, buyouts, and spin-outs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Collins to Avoid 'Manels'

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Patient Dies Following Fecal Transplant

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

From Pigs to Monkeys

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

This Week in Science

In Science this week: almond reference genome, and more.

Featured White Papers

Compatibility of liquid biopsy assays on multiple sequencing platforms

BlueBee Data Security & Compliance

Whole Genome Sequencing of Microbial Communities for Scaling Microbiome and Metagenomic Studies

NGS is Accelerating Therapeutic Antibody Discovery - What Lies Beyond?

Jun

17

Featured Webinar

Personal and Clinical Utility of Polygenic Risk Scores: A Review of the Evidence

This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.

Menu